MPG.eBooks - Author Search Results

1

CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis

Published 2020

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

2

CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy

Published 2019

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

3

CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy

Published 2019

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

4

CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis

Published 2020

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

5

CADTH Canadian Drug Expert Committee recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) : indication: in adults, as an adjunct to standard of care therapy, for the...

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

6

CADTH Canadian Drug Expert Committee recommendation: Nintedanib (Ofev -- Boehringer Ingelheim Canada Inc.) : indication: chronic fibrosing interstitial lung diseases

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

7

CADTH Canadian Drug Expert Committee recommendation: Glucagon nasal powder (Baqsimi -- Eli Lilly Canada Inc) : indication: for the treatment of severe hypoglycemia (SH) reactions w...

Published 2020

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

8

CADTH Canadian Drug Expert Committee recommendation: Tafamidis meglumine (Vyndaqel - Pfizer Canada ULC) : indication : for the treatment of adult patients with cardiomyopathy due t...

Published 2020

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

9

CADTH Canadian Drug Expert Committee recommendation: Sodium zirconium cyclosilicate (Lokelma -- Astrazeneca Canada Inc.) : indication: hyperkalemia

Published 2020

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

10

CADTH Canadian Drug Expert Committee recommendation: Belimumab (Benlysta subcutaneous [SC] -- GlaxoSmithKline Inc.) : indication: systemic lupus erythematosus (SLE)

Published 2020

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

11

CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.) : indication: chronic migraine

Published 2019

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

12

CADTH Canadian Drug Expert Committee recommendation: Teduglutide (Revestive -- Shire Pharmaceuticals Ireland Limited) : indication: treatment of adults and pediatric patients 1 yea...

Published 2019

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

13

CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.) : indication : coronary artery disease with or without peripheral artery disease

Published 2018

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

14

CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) : indication : diabetic macular edema

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

15

CADTH Canadian Drug Expert Committee recommendation: Sucroferric oxyhydroxide (Velphoro -- Vifor Fresenius Medical Care Renal Pharma Ltd.) : indication : for the control of serum p...

Published 2019

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

16

Pharmacoeconomic review report: Savuconazole (Cresemba) (AVIR pharma inc.)

Published 2019

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

17

CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication: for the treatment of adult patients with moderately to severely activ...

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Read Now

18

CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.) : indication: chronic migraine

Published 2019

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

19

CADTH Canadian Drug Expert Committee recommendation: Crisaborole (Eucrisa -- Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patie...

Published 2019

CADTH

“...CADTH Canadian Drug Expert Committee...”

Read Now

20

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

“...CADTH Canadian Drug Expert Committee...”